Humana Statistics
Total Valuation
Humana has a market cap or net worth of $31.05 billion. The enterprise value is $39.09 billion.
Important Dates
The last earnings date was Wednesday, April 29, 2026, before market open.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Jun 26, 2026 |
Share Statistics
Humana has 120.06 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 120.06M |
| Shares Outstanding | 120.06M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 102.50% |
| Float | 119.75M |
Valuation Ratios
The trailing PE ratio is 26.41 and the forward PE ratio is 23.40. Humana's PEG ratio is 1.57.
| PE Ratio | 26.41 |
| Forward PE | 23.40 |
| PS Ratio | 0.22 |
| Forward PS | 0.18 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 4.30 |
| P/FCF Ratio | 23.33 |
| P/OCF Ratio | 16.09 |
| PEG Ratio | 1.57 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.63, with an EV/FCF ratio of 30.73.
| EV / Earnings | 34.59 |
| EV / Sales | 0.28 |
| EV / EBITDA | 11.63 |
| EV / EBIT | 12.63 |
| EV / FCF | 30.73 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.77 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 4.04 |
| Debt / FCF | 11.30 |
| Interest Coverage | 4.66 |
Financial Efficiency
Return on equity (ROE) is 6.28% and return on invested capital (ROIC) is 8.00%.
| Return on Equity (ROE) | 6.28% |
| Return on Assets (ROA) | 3.64% |
| Return on Invested Capital (ROIC) | 8.00% |
| Return on Capital Employed (ROCE) | 9.16% |
| Weighted Average Cost of Capital (WACC) | 6.64% |
| Revenue Per Employee | $2.05M |
| Profits Per Employee | $16,851 |
| Employee Count | 67,060 |
| Asset Turnover | 2.58 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $239.00 million in taxes.
| Income Tax | 239.00M |
| Effective Tax Rate | 17.27% |
Stock Price Statistics
The stock price has increased by +0.69% in the last 52 weeks. The beta is 0.68, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +0.69% |
| 50-Day Moving Average | 195.82 |
| 200-Day Moving Average | 240.89 |
| Relative Strength Index (RSI) | 79.74 |
| Average Volume (20 Days) | 1,607,821 |
Short Selling Information
The latest short interest is 5.42 million, so 4.52% of the outstanding shares have been sold short.
| Short Interest | 5.42M |
| Short Previous Month | 4.98M |
| Short % of Shares Out | 4.52% |
| Short % of Float | 4.53% |
| Short Ratio (days to cover) | 3.06 |
Income Statement
In the last 12 months, Humana had revenue of $137.20 billion and earned $1.13 billion in profits. Earnings per share was $9.36.
| Revenue | 137.20B |
| Gross Profit | 19.22B |
| Operating Income | 3.10B |
| Pretax Income | 1.38B |
| Net Income | 1.13B |
| EBITDA | 3.36B |
| EBIT | 3.10B |
| Earnings Per Share (EPS) | $9.36 |
Full Income StatementBalance Sheet
The company has $21.97 billion in cash and $14.37 billion in debt, with a net cash position of -$9.42 billion or -$78.46 per share.
| Cash & Cash Equivalents | 21.97B |
| Total Debt | 14.37B |
| Net Cash | -9.42B |
| Net Cash Per Share | -$78.46 |
| Equity (Book Value) | 18.65B |
| Book Value Per Share | 154.75 |
| Working Capital | 16.57B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.84 billion and capital expenditures -$572.00 million, giving a free cash flow of $1.27 billion.
| Operating Cash Flow | 1.84B |
| Capital Expenditures | -572.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 641.00M |
| Free Cash Flow | 1.27B |
| FCF Per Share | $10.59 |
Full Cash Flow StatementMargins
Gross margin is 14.01%, with operating and profit margins of 2.26% and 0.82%.
| Gross Margin | 14.01% |
| Operating Margin | 2.26% |
| Pretax Margin | 1.01% |
| Profit Margin | 0.82% |
| EBITDA Margin | 2.45% |
| EBIT Margin | 2.26% |
| FCF Margin | 0.93% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.37%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.37% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.83% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.42% |
| Earnings Yield | 3.81% |
| FCF Yield | 4.29% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $248.25, which is -4.02% lower than the current price. The consensus rating is "Hold".
| Price Target | $248.25 |
| Price Target Difference | -4.02% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 10.18% |
| EPS Growth Forecast (5Y) | 20.41% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
